Presentation AHA 2022 Bivalirudin Plus a High-dose Infusion Versus Heparin Monotherapy in Patients with STEMI Undergoing Primary PCI: The BRIGHT-4 Trial Presenter: Gregg W. Stone November 07, 2022 REGISTER for free or LOG IN to view this content Coronary CAD Pharma Presentation AHA 2022 STEMI Up Next Presentation AHA 2022 Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial Presenter: Michelle L. O’Donoghue November 07, 2022 We Recommend
Presentation AHA 2022 Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial Presenter: Michelle L. O’Donoghue November 07, 2022